Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt · Delayed Price · Currency is EGP

112.21

-0.27 (-0.24%)

At close: Nov 12, 2026

Market Cap	18.94B +42.9%
Revenue (ttm)	9.88B +12.1%
Net Income	1.24B +8.3%
EPS	7.65 +6.0%
Shares Out	168.76M
PE Ratio	14.67
Forward PE	17.42
Dividend	1.50 (1.34%)
Ex-Dividend Date	Apr 28, 2026

Volume	625,196
Open	112.48
Previous Close	112.48
Day's Range	111.01 - 113.89
52-Week Range	67.50 - 178.99
Beta	0.59
Analysts	Hold
Price Target	108.20 (-3.57%)
Est. Earnings	Feb 25, 2027

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company provides analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolics; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It exports its products. The company was incorporated in 1980 and is based in 10th of Ramadan City, Egypt. [Read more]

Industry Pharmaceutical Preparations

Founded 1980

Country Egypt

Stock Exchange Egyptian Stock Exchange

Ticker Symbol PHAR

Full Company Profile

Financial Performance

In 2025, EGX:PHAR's revenue was 9.44 billion, an increase of 24.38% compared to the previous year's 7.59 billion. Earnings were 1.44 billion, an increase of 31.57%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for PHAR stock is "Hold." The 12-month stock price target is E£108.20, which is a decrease of -3.57% from the latest price.

Price Target

E£108.20

(-3.57% downside)

Analyst Consensus: Hold

Stock Forecasts